Chemomab Therapeutics Ltd. Adjustments For Income Tax Expense
Chemomab Therapeutics Ltd. (CMMB) reported Adjustments For Income Tax Expense of $621.00 thousand for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForIncomeTaxExpense · last filed 2019-04-24
| Period end | Adjustments For Income Tax Expense 12 month |
|---|---|
| 2018-12-31 | $621.00K 20-F · filed 2019-04-24 |
| 2017-12-31 | $323.00K 20-F · filed 2019-04-24 |
| 2016-12-31 | $137.00K 20-F · filed 2019-04-24 |